Target type: biologicalprocess
Any process that alters the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of melanin. [GOC:jid]
The regulation of melanin biosynthesis is a complex and tightly controlled process involving multiple signaling pathways, transcription factors, and enzymes. Melanin, a pigment responsible for skin, hair, and eye color, is produced through a series of enzymatic reactions within melanocytes, specialized pigment-producing cells located in the skin, hair follicles, and eyes.
The process starts with the amino acid tyrosine, which is converted to L-DOPA (3,4-dihydroxyphenylalanine) by the enzyme tyrosinase. L-DOPA is then further oxidized by tyrosinase to dopaquinone, the first committed step in melanin biosynthesis. Dopaquinone can then follow two distinct pathways:
1. Eumelanin pathway: Dopaquinone is converted to dopachrome by the enzyme dopachrome tautomerase. Dopachrome is further processed through a series of reactions, ultimately leading to the production of eumelanin, a dark brown-black pigment responsible for brown and black hair and skin color.
2. Pheomelanin pathway: Dopaquinone can also react with cysteine to form a cysteine-dopaquinone adduct, which is then converted to pheomelanin, a reddish-yellow pigment responsible for red and blond hair color.
The regulation of melanin biosynthesis is influenced by various factors, including:
- Genetic factors: Genes encoding enzymes involved in melanin biosynthesis, such as tyrosinase, tyrosinase-related protein 1 (TYRP1), and tyrosinase-related protein 2 (TYRP2), play a crucial role in determining individual melanin levels. Mutations in these genes can lead to albinism or other pigmentation disorders.
- Hormones: Hormones such as melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) stimulate melanin production by activating melanocortin receptors on melanocytes.
- Ultraviolet (UV) radiation: Exposure to UV radiation triggers increased melanin production, providing protection against UV damage. This process is mediated by a complex signaling cascade involving factors like p53, NF-κB, and MAP kinases.
- Nutritional factors: Certain nutrients, such as tyrosine, copper, and vitamin D, are essential for melanin synthesis.
The intricate regulation of melanin biosynthesis ensures appropriate pigmentation and protects against environmental stresses. Dysregulation of this process can lead to various skin disorders, including albinism, vitiligo, and melanoma.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cystine/glutamate transporter | A cystine/glutamate transporter that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UPY5] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
mesalamine | mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position. Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) | amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols | non-steroidal anti-inflammatory drug |
sulfapyridine | sulfapyridine : A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position. Sulfapyridine: Antibacterial, potentially toxic, used to treat certain skin diseases. | pyridines; substituted aniline; sulfonamide; sulfonamide antibiotic | antiinfective agent; dermatologic drug; drug allergen; environmental contaminant; xenobiotic |
sulfasalazine | sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position. Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) | ||
cysteine | cysteine; cysteine zwitterion; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite | |
quisqualic acid | Quisqualic Acid: An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis. | non-proteinogenic alpha-amino acid | |
serine o-sulfate | L-serine O-sulfate : A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine. serine O-sulfate: RN given refers to (L)-isomer | L-serine derivative; non-proteinogenic L-alpha-amino acid; O-sulfoamino acid | |
homocysteic acid | homocysteic acid : A non-proteinogenic alpha-amino acid that is homocysteine in which the thiol group has benn oxidised to the corresponding sulfonic acid. homocysteic acid: promotes growth in hypophysectomized rats; RN given refers to parent cpd L-homocysteic acid : A homocysteic acid with L-configuration. | homocysteic acid | NMDA receptor agonist |
susalimod | susalimod: analogue of sulphasalazine, was designed for use in the treatment of rheumatoid arthritis | ||
erastin | erastin : A member of the class of quinazolines that is quinazolin-4(3H)-one in which the hydrogens at positions 2 and 3 are replaced by 1-{4-[(4-chlorophenoxy)acetyl]piperazin-1-yl}ethyl and 2-ethoxyphenyl groups, respectively. It is an inhibitor of voltage-dependent anion-selective channels (VDAC2 and VDAC3) and a potent ferroptosis inducer. erastin: an antineoplastic agent; structure in first source | aromatic ether; diether; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; quinazolines; tertiary carboxamide | antineoplastic agent; ferroptosis inducer; voltage-dependent anion channel inhibitor |